{"organizations": [], "uuid": "0a600121fabd17df8ab151300f8552bf5a98c2e5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180111.html", "section_title": "Archive News &amp; Video for Thursday, 11 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-immunovia-signs-loi-with-dd2-cente/brief-immunovia-signs-loi-with-dd2-center-idUSASM000I1L", "country": "US", "domain_rank": 408, "title": "BRIEF-Immunovia Signs LoI With DD2 Center", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.002, "site_type": "news", "published": "2018-01-11T21:33:00.000+02:00", "replies_count": 0, "uuid": "0a600121fabd17df8ab151300f8552bf5a98c2e5"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-immunovia-signs-loi-with-dd2-cente/brief-immunovia-signs-loi-with-dd2-center-idUSASM000I1L", "ord_in_thread": 0, "title": "BRIEF-Immunovia Signs LoI With DD2 Center", "locations": [], "entities": {"persons": [], "locations": [{"name": "denmark", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "immunovia ab", "sentiment": "negative"}, {"name": "thomson reuters trust principles", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 11 (Reuters) - IMMUNOVIA AB (PUBL):\n* ‍SIGNED A LETTER OF INTENT FOR COLLABORATION WITH DANISH CENTER FOR STRATEGIC RESEARCH INTO TYPE 2 DIABETES​\n* ‍INTENTION IS DD2 CENTER WILL BE PART OF GROUNDBREAKING PANDIA-1 PROSPECTIVE STUDY INTO NEW ONSET TYPE 2 DIABETICS​\n* IMMUNOVIA ACCELERATES PANCREAS CANCER STUDY OF NEW ONSET DIABETICS BY ADDING DENMARK‘S DIABETES CENTER FOR STRATEGIC RESEARCH-DD2 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-11T21:33:00.000+02:00", "crawled": "2018-01-12T18:36:08.094+02:00", "highlightTitle": ""}